Submit Deal

TROGENIX LTD

HQ - Edinburgh

Summary

Trogenix is a biopharmaceutical company engaged in developing, manufacturing, and commercializing prescription medicines for central nervous system disorders and pain management.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 70 M

Avg. Deal Size£ 70 M

Market Context

Senior Management

Ken Macnamara
CEO

Sort

06 Oct 2025|United Kingdom|Biotechnology

Target: TROGENIX LTD

Bidder: 4BIO CAPITAL

8 Service Providers

1 Target | 7 Bidder

8 Dealmakers

1 Target | 7 Bidder

£ 70 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy